Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:59 PM
Ignite Modification Date:
2025-12-24 @ 3:59 PM
NCT ID:
NCT05775692
Eligibility Criteria:
Inclusion Criteria:
Newborn （0-28d） with fluconazole against infectious diseases. The anti-infective therapy includes drugs commonly used in children infectious diseases.
Newborns infectious diseases include pneumonia, sepsis, purulent meningitis and other diseases with infection.
Informed consent signed by the parents and/or guardians.
Exclusion Criteria:
1. Allergic to any class of antibiotics;
2. Receiving other experimental drugs;
3. There are other factors that clinicians consider unsuitable for inclusion in the study.
Sex:
ALL
Minimum Age:
1 Minute
Maximum Age:
28 Days
Study:
NCT05775692
Study Brief:
Protocol Section:
NCT05775692